Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Depreciation and Depletion: 2014-2024

Historic Depreciation and Depletion for China Pharma Holdings (CPHI) over the last 11 years, with Dec 2024 value amounting to $2.2 million.

  • China Pharma Holdings' Depreciation and Depletion fell 67.95% to $158,076 in Q3 2025 from the same period last year, while for Sep 2025 it was $800,921, marking a year-over-year decrease of 66.63%. This contributed to the annual value of $2.2 million for FY2024, which is 14.19% down from last year.
  • Latest data reveals that China Pharma Holdings reported Depreciation and Depletion of $2.2 million as of FY2024, which was down 14.19% from $2.5 million recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Depreciation and Depletion registered a high of $3.0 million during FY2021, and its lowest value of $2.2 million during FY2024.
  • Its 3-year average for Depreciation and Depletion is $2.5 million, with a median of $2.5 million in 2023.
  • As far as peak fluctuations go, China Pharma Holdings' Depreciation and Depletion climbed by 15.35% in 2021, and later decreased by 14.19% in 2024.
  • Over the past 5 years, China Pharma Holdings' Depreciation and Depletion (Yearly) stood at $2.6 million in 2020, then climbed by 15.35% to $3.0 million in 2021, then dropped by 12.65% to $2.7 million in 2022, then declined by 5.03% to $2.5 million in 2023, then declined by 14.19% to $2.2 million in 2024.